Replies to post #271504 on Innovation Pharmaceuticals Inc (IPIX)

[MackG]

Because it's a new day since Amgen's $13.4 Billion Otezla Buy.

"A key aspect of Brilacidin's mechanism of action, inhibiting Phosphodiesterase 4 (PDE4), may further support its use in treating Asthma, Psoriasis, Psoriatic Arthritis and Chronic Obstructive Pulmonary Disease (COPD), alongside other chronic autoimmune conditions."

[Empiricst1]

With no disrespect to the board, which I generally respect very much, isn't it possible that, by and large, we are mostly a bunch of small time players. The daily amounts of shares traded divided by pennies ends up in pretty small $s in the general scheme of things.